• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑脊髓液中转移性乳腺癌细胞与原发性乳腺癌组织的一致 HER2 状态。

Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.

机构信息

Center for Breast Cancer, National Cancer Center, 111 Jeongbalsan-ro, Ilsan-donggu, Goyang-si, Gyeonggi-do 410-769, Republic of Korea.

出版信息

Breast Cancer Res Treat. 2010 Aug;123(1):125-8. doi: 10.1007/s10549-009-0627-3. Epub 2009 Nov 15.

DOI:10.1007/s10549-009-0627-3
PMID:19916047
Abstract

It is not known whether the HER2 status of malignant CSF cells coincides with that of the original breast carcinoma cells. We investigated whether CSF cytology specimens were suitable to evaluate HER2 status by fluorescence in situ hybridization (FISH) in patient with leptomeningeal metastasis (LM). Both formalin-fixed paraffin-embedded (FFPE) breast cancer tissue and liquid based CSF cytology specimens were evaluated for HER2 status in 16 patients with LM. We evaluated HER2 gene amplification using FISH on destained CSF cytology slides containing a minimum of 20 malignant cells per slide, and compared these with the HER2 status by immunohistochemistry (IHC) or FISH in FFPE tissues. HER2 was considered positive when the HER2:CEP17 ratio was >or=2.0 or IHC 3+. Of 16 cases, four were HER2 positive and 12 were HER2 negative by FISH analysis in CSF cytology. All CSF-positive cases were HER2 positive by IHC in FFPE tissue. Of 12 HER2 FISH-negative cases in CSF cytology, 10 were HER2 negative (IHC 0 or 1+) and two were IHC 2+ in FFPE tissue. Two IHC 2+ cases had HER2:CEP17 ratios of 1.27 and 2.1, respectively, by FISH in FFPE tissue. As a result, the HER2 status concordance rate between metastatic breast cancer cells in CSF and FFPE primary tissue by IHC and FISH was very high. When CSF cytology specimens were appropriately prepared and had adequate cellularity without dry artifacts, the CSF cytology was suitable to evaluate HER2 status by FISH analysis in patients with LM.

摘要

尚不清楚恶性 CSF 细胞的 HER2 状态是否与原发性乳腺癌细胞的 HER2 状态一致。我们通过荧光原位杂交(FISH)检测了 CSF 细胞学标本是否适合评估脑膜转移(LM)患者的 HER2 状态。对 16 例 LM 患者的 CSF 细胞学标本和福尔马林固定石蜡包埋(FFPE)乳腺癌组织进行了 HER2 状态评估。我们使用 FISH 评估了脱染 CSF 细胞学载玻片上至少 20 个恶性细胞中 HER2 基因的扩增情况,并将其与 FFPE 组织中 HER2 状态的免疫组化(IHC)或 FISH 进行了比较。当 HER2:CEP17 比值>或=2.0 或 IHC 3+时,HER2 被认为是阳性。在 16 例病例中,4 例 CSF 细胞学检测 HER2 阳性,12 例 CSF 细胞学检测 HER2 阴性。所有 CSF 阳性病例的 FFPE 组织 IHC 均为阳性。在 CSF 细胞学中,12 例 HER2 FISH 阴性病例中,10 例为 HER2 阴性(IHC 0 或 1+),2 例为 IHC 2+。FFPE 组织中的 2 例 IHC 2+病例的 HER2:CEP17 比值分别为 1.27 和 2.1。因此,通过 IHC 和 FISH,转移性乳腺癌细胞在 CSF 中的 HER2 状态与 FFPE 原发性组织的一致性非常高。当 CSF 细胞学标本经过适当的准备并有足够的细胞数量且没有干燥伪影时,CSF 细胞学标本适合通过 FISH 分析评估 LM 患者的 HER2 状态。

相似文献

1
Concordant HER2 status between metastatic breast cancer cells in CSF and primary breast cancer tissue.脑脊髓液中转移性乳腺癌细胞与原发性乳腺癌组织的一致 HER2 状态。
Breast Cancer Res Treat. 2010 Aug;123(1):125-8. doi: 10.1007/s10549-009-0627-3. Epub 2009 Nov 15.
2
Analysis of ERBB2 and TOP2A gene status using fluorescence in situ hybridization versus immunohistochemistry in localized breast cancer.在局部乳腺癌中使用荧光原位杂交与免疫组织化学分析ERBB2和TOP2A基因状态
Neoplasma. 2006;53(5):393-401.
3
Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).显色原位杂交(CISH)检测乳腺癌和胃癌中 HER2 基因扩增:与免疫组织化学(IHC)和荧光原位杂交(FISH)的比较。
Pathol Int. 2012 Nov;62(11):728-34. doi: 10.1111/j.1440-1827.2012.02862.x.
4
Histological tumor grade correlates with HER2/c-erB-2 status in invasive breast cancer: a comparative analysis between immunohistochemical (CB11 clone and Herceptest), FISH and differential PCR procedures.浸润性乳腺癌的组织学肿瘤分级与HER2/c-erB-2状态相关:免疫组织化学(CB11克隆和赫赛汀检测)、荧光原位杂交和差异聚合酶链反应方法之间的比较分析
Arkh Patol. 2003 Jan-Feb;65(1):50-5.
5
HER2 status in breast cancer determined by IHC and FISH: comparison of the results.通过免疫组织化学(IHC)和荧光原位杂交(FISH)检测乳腺癌中的人表皮生长因子受体2(HER2)状态:结果比较
Pol J Pathol. 2004;55(4):165-71.
6
Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer.荧光原位杂交技术在确定乳腺癌HER2基因扩增中的预后效用
Oncol Rep. 2008 Mar;19(3):651-6.
7
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patients.通过荧光原位杂交和免疫组织化学比较HER2状态,以预测淋巴结阳性乳腺癌患者从基于阿霉素的辅助治疗剂量递增中获益的情况。
J Clin Oncol. 2005 Jul 1;23(19):4287-97. doi: 10.1200/JCO.2005.11.012.
8
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsies.乳腺癌中的HER2分析:FISH无信息价值的癌症活检中免疫反应性降低
Int J Oncol. 2004 Dec;25(6):1551-7.
9
[Availability of fine needle aspirates for the assessment of HER2 gene amplification in invasive breast cancer patients].[用于评估浸润性乳腺癌患者HER2基因扩增的细针穿刺抽吸物的可用性]
Korean J Lab Med. 2008 Oct;28(5):392-9. doi: 10.3343/kjlm.2008.28.5.392.
10
Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer.胃癌中通过荧光原位杂交评估的HER2基因扩增与通过免疫组织化学评估的HER2蛋白表达的比较。
Oncol Rep. 2006 Jan;15(1):65-71.

引用本文的文献

1
Long-term response to sequential anti-HER2 therapies including trastuzumab-deruxtecan in a patient with HER2-positive metastatic breast cancer with leptomeningeal metastases: a case report and review of the literature.1例HER2阳性转移性乳腺癌伴软脑膜转移患者对包括曲妥珠单抗-德曲妥珠单抗在内的序贯抗HER2治疗的长期反应:1例病例报告及文献复习
Front Oncol. 2024 Jan 10;13:1210873. doi: 10.3389/fonc.2023.1210873. eCollection 2023.
2
Leptomeningeal Metastasis: A Review of the Pathophysiology, Diagnostic Methodology, and Therapeutic Landscape.脑膜转移:病理生理学、诊断方法学和治疗全景的综述。
Curr Oncol. 2023 Jun 19;30(6):5906-5931. doi: 10.3390/curroncol30060442.
3
Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis.
柔脑膜癌病与乳腺癌:关于诊断、治疗和预后的当前证据的系统评价
Drugs Context. 2021 Oct 26;10. doi: 10.7573/dic.2021-6-6. eCollection 2021.
4
Breast leptomeningeal disease: a review of current practices and updates on management.乳腺软脑膜疾病:当前诊治实践的综述及相关更新。
Breast Cancer Res Treat. 2019 Sep;177(2):277-294. doi: 10.1007/s10549-019-05317-6. Epub 2019 Jun 17.
5
Clinical predictors of long-term survival in HER2-positive metastatic breast cancer.HER2阳性转移性乳腺癌长期生存的临床预测因素
Breast Cancer Res Treat. 2016 Feb;155(3):589-95. doi: 10.1007/s10549-016-3705-3. Epub 2016 Feb 13.
6
Carcinomatous meningitis: Leptomeningeal metastases in solid tumors.癌性脑膜炎:实体瘤的软脑膜转移
Surg Neurol Int. 2013 May 2;4(Suppl 4):S265-88. doi: 10.4103/2152-7806.111304. Print 2013.
7
Breast cancer brain metastases: new directions in systemic therapy.乳腺癌脑转移:全身治疗的新方向
Ecancermedicalscience. 2013 Apr 18;7:307. doi: 10.3332/ecancer.2013.307. Print 2013.
8
Detection of cancer cells in the cerebrospinal fluid: current methods and future directions.检测脑脊液中的癌细胞:当前方法和未来方向。
Fluids Barriers CNS. 2011 Mar 3;8(1):14. doi: 10.1186/2045-8118-8-14.